By Malvika Gurung
Investing.com -- Shares of the chemical manufacturing company Tatva Chintan Pharma Chem (NS: TATV ) slumped 8.47% to Rs 2,626 apiece at 12:02 pm on Tuesday, after diving 9% in early trade to touch the intraday low at Rs 2597.05 apiece on the BSE.
The company’s shares tanked a day after it released earnings results for the quarter ending December, underlining a weak quarterly operating performance.
Even though the company’s consolidated net profit and total revenue jumped up to 31% in Q3 on a YoY basis, its EBITDA declined 6% YoY to Rs 23 crore and the company’s margin reduced to 22% in Q3 FY22, compared to 32% in Q3 FY21.
The specialty chemicals manufacturer, listed in July 2021 at a 95% premium compared to its issue price of Rs 1,083, has zoomed over 150% in about 6 months.
It reported a consolidated net profit of Rs 22.8 crore, up 9.2% YoY and total revenue of Rs 104.6 crore, up 31% YoY, in Q3 FY22.
Also, in the Apr-Dec 2021 period, the company’s net profit rallied 152% to Rs 78.36 crore, and revenue surged 75% to Rs 335.11 crore, compared to the same period in 2020.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.
I don't know how to useLike 0